 |
Senior Member
|
|
Join Date: Aug 2011
Posts: 42,117
|
|
|
Senior Member
Join Date: Aug 2011
Posts: 42,117
|
CNN)A leading Chinese Covid-19 vaccine developed by Sinovac Biotech was just 50.38% effective in late-stage trials in Brazil, significantly lower than earlier results showed, according to a statement published by the government of Sao Paulo Tuesday.
While the number exceeds the threshold required for regulatory approval, it falls far below the 78% previously announced, raising questions as to the veracity of the data and fueling skepticism over the apparent lack of transparency regarding Chinese vaccines.
Sent from my iPhone using Tapatalk Pro
|